In addition to establishing an Exposure Limit (in workplace air), the review will also provide ”good practice” guidance on the most up to date procedures for biological monitoring of certain blood or urine metabolites associated with the substance to ensure the substance either does not exist or is at a safe level that would not cause any adverse effect.